Page 2 - Diagnostics

Amazon enters India's $15 bn diagnostics market with at-home testing

Amazon enters India's $15 bn diagnostics sector with at-home test collection, digital reports and integrated health services through Amazon Medical across six cities

Suraksha Diagnostics to invest ₹200 cr to set up 20 centres in east India

Suraksha Diagnostics on Wednesday said it will invest Rs 200 crore to set up over 20 advanced imaging centres across eastern India. The plan, which will be executed in collaboration with United Imaging, is aimed at expanding access to advanced diagnostic services in tier 2 and tier 3 cities, enhancing both affordability and healthcare quality in smaller towns and semi-urban regions, it said. No timeline was, however, revealed for the investment rollout. "This collaboration will assist us in expanding our reach and offer high-quality diagnostic services to a large population in eastern India," Suraksha Diagnostics CMD Somnath Chatterjee said. United Imaging will supply cutting-edge imaging solutions, while Suraksha Diagnostics will leverage its existing network and operational expertise to set up the new centres, the company said. Suraksha Diagnostics raised Rs 846.25 crore through an IPO in December for funding its expansion plans. At present, it operates 59 diagnostic centres an

Dr Lal PathLabs Q4 profit rises 81% on volume growth, geographic expansion

The company's revenue from operations also rose to Rs 603 crore in Q4FY25, a 10.5 per cent Y-o-Y growth from Rs 545 crore reported in Q4FY24

Dr Lal Path Labs Q4FY25 results: Net profit rises 83.2% to ₹155 crore

The company's consolidated net profit jumped 83.2 per cent year-on-year to Rs 1.55 billion (about $18 million) in the quarter ended March 31

This smallcap stock zooms 32% in 1 week, nears 52-week high. Do you own?

Share price of Thyrocare Technologies has moved higher by 11 per cent to ₹938.65 on the BSE in Friday's intra-day trade and recovered 13 per cent from its intra-day low of ₹830.90.

Metropolis Healthcare expands footprint in North with Dapic acquisition

With its third acquisition in recent times, Metropolis' Ameera Shah said the firm will make another deal this financial year

In India, 3 in 5 die following cancer diagnosis, women more affected: Study

Three in every five people in India succumb to cancer following diagnosis with women bearing a "disproportionate burden" compared to men, an analysis of global cancer data has estimated. The incidence to mortality ratio in the US was found to be about one in four, while in China it was one in two, according to the results published in 'The Lancet Regional Health Southeast Asia' journal. The Indian Council of Medical Research (ICMR) study found that India ranked third highest in cancer incidence, after China and the US, and accounted for over 10 per cent of the world's cancer-related deaths, ranking second after China. Researchers also projected that in the coming two decades, India will face a formidable challenge in managing deaths related to cancer incidence, with a yearly increase of two per cent in cases as the population ages. The team examined trends in 36 types of cancer across age groups and genders in India over the past 20 years, using the Global Cancer Observatory ...

Dr Lal Q3FY25 results: PAT jumps 19% to Rs 98 crore as volumes grow

As for Suburban Diagnostics, an arm of Dr Lal Pathlabs, revenue growth was 9.2 per cent in Q3

ICMR proposes revised version of National Essential Diagnostics List

The ICMR has proposed a revised version of the National Essential Diagnostics List (NEDL), which enumerates the minimum number of tests that should be available at various levels of healthcare facilities in the country. According to the revised draft, nine types of diagnostic tests, including those for diabetes, Malaria, TB, HIV and syphilis should be made available at the health centres in village-level health facilities. Ayushman Arogya Mandirs should have facilities for Hepatitis B tests available in addition to the nine diagnostics that are available at the village-level health centres. The revised draft list has been prepared incorporating inputs from relevant stakeholders and feedback from multiple consultation meetings. It builds upon the first list and provides recommendations for diagnostic tests across various levels of healthcare facilities, including village-level facilities, Ayushman Arogya Mandirs, primary health centre (PHCs), community health centres (CHCs), sub ...

Diagnostic demand rises in towns; organised players lead expansion plans

The Healthcare Federation of India reports that over 50 per cent of aspirational districts identified by NITI Aayog, which lack essential infrastructure, are served by diagnostic chains

What is Angelman Syndrome that Colin Farrell's son was diagnosed with?

The 48-year-old actor launched Colin Farrell Foundation initiating and promoting progressive programs for people who are struggling with this intellectual disability

Aurobindo arm TheraNym inks pact with MSD for biologics manufacturing

This agreement follows previous disclosures by Aurobindo Pharma about expanding its biologics manufacturing facilities and exploring contract manufacturing operations (CMO) for biologicals

Reliance Retail Ventures plans expanding in diagnostic healthcare: Report

Company said to be considering acquiring majority stake in dedicated diagnostic services firm

Vijaya Diagnostic extends rally, surges 20% in 3 days on healthy Q4 results

In past one year, the market price of Vijaya has been more than doubled or zoomed 116%, as against 17% rise in the S&P BSE Sensex.

Tirupati diagnostics and labs-the social entrepreneurs in diagnostics that modern India needs

.

Agilus Diagnostics signs agreement with SEAS to start services in Oman

The participation aims to add to the diagnostic service provider's international portfolio. Its international network consists of several centres and pick-up points (PUPs) across multiple locations

Digital lab at fingertips: Neodocs aims to perform 100 mn tests in 3 years

The company employs diagnostic laboratory (lab) principles through a smartphone application (app) and a test card

ICMR invites suggestions for revising national essential diagnostics list

It is unclear whether the finalisation of the NEDL will lead to price capping of diagnostic tests in line with drugs

Decoding the Innovations and Disruptions in India's Highly-competitive Diagnostics Landscape

.

Practro aims profitability next fiscal, IPO in works: CEO Shashank ND

Tencent-backed healthcare and diagnostics app Practo is aiming to turn profitable in next fiscal and is looking at a stock exchange listing with an initial public offering (IPO) soon, its co-founder and CEO Shashank ND said. Practo is looking to enhance presence in smaller cities and towns and leverage AI to analyse data and provide much better analysis and outcomes in healthcare. In an interview with PTI, Shashank said the startup is already cash flow positive. "This year we will grow by a good healthy margin... Our EBITDA would have improved dramatically from last year. We will be near break-even this year and next year is when we really will be able to show significant profits." Founded in 2008, Practo connects doctors with patients and offers several ancillary services such as telemedicine. Income from diagnostic and consulting services formed 50 per cent of the total operating revenue. In the 2022-23 fiscal (April 2022 to March 2023), the Bengaluru-headquartered firm halved it